{
  "docId": "019de077-7395-77e8-a759-85ee5ceb6441",
  "docSlug": "d10c7e5183f0665a04c27575aa737d7a",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 42 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2025-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 21,
  "pageCount": 42,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "other",
  "function": "other",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": "The slide content is obscured by a large grey box, leaving only the title visible.",
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de077-7395-77e8-a759-85ee5ceb6441/21",
  "deckHref": "/decks/019de077-7395-77e8-a759-85ee5ceb6441",
  "deckJsonHref": "/decks/019de077-7395-77e8-a759-85ee5ceb6441.json",
  "deckAnchorHref": "/decks/019de077-7395-77e8-a759-85ee5ceb6441#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "BioPharma – select Phase III readouts in 2025",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "038b0ea0-1d2a-4ed2-9e95-f5adf51a610a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 25,
      "from": 17,
      "beatId": "e47ffa97-7762-483f-b704-045948218cac",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Visualization",
      "beatSlug": "monroes-sequence-visualization",
      "evidence": "The slides use visual aids and key messages to help the audience visualize the company's growth momentum and future prospects.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 25,
      "from": 17,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "0642f45f-f82f-4cf0-ac20-36b05c74bfb1",
      "evidence": "The slides use the golden circle framework to explain the company's growth momentum and future prospects.",
      "position": 1,
      "objective": "Why is AstraZeneca's growth sustainable?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}